Future studies are needed to identify which people with MS are most likely to benefit from taking a GLP-1, the safest dosing strategies, and whether these medications have long-term disease-modifying effects in MS, she says
Huang PH, Xirasagar S, Chen JH, Cheng YF, Kuo NW, Lin HC
Medical treatment is provided and supervised by licensed healthcare professionals.
Effects of Sodium-glucose Cotransporter 2 Inhibitors on Amputation, Bone Fracture, and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Using an Alternative Measure to the Hazard Ratio
A total of 992 patients were identified as using an SGLT2i without ever having been prescribed a GLP-1 RA